24/08/2017
Auris Medical Announces Receipt of Nasdaq Notice
Auris Medical Holding AG("the Company", NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that onAugust 18, 2017 [...]
